Tony Marchand

1.8k total citations
40 papers, 602 citations indexed

About

Tony Marchand is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Tony Marchand has authored 40 papers receiving a total of 602 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hematology, 14 papers in Genetics and 14 papers in Pathology and Forensic Medicine. Recurrent topics in Tony Marchand's work include Lymphoma Diagnosis and Treatment (12 papers), Hematopoietic Stem Cell Transplantation (10 papers) and Chronic Lymphocytic Leukemia Research (9 papers). Tony Marchand is often cited by papers focused on Lymphoma Diagnosis and Treatment (12 papers), Hematopoietic Stem Cell Transplantation (10 papers) and Chronic Lymphocytic Leukemia Research (9 papers). Tony Marchand collaborates with scholars based in France, United States and United Kingdom. Tony Marchand's co-authors include Sandra Pinho, Paul S. Frenette, Claus Nerlov, Qiaozhi Wei, Thierry Lamy, Céline Pangault, Karin Tarte, Thierry Fest, Frédéric Mourcin and Fabrice Uhel and has published in prestigious journals such as Nature, Nature Communications and Blood.

In The Last Decade

Tony Marchand

34 papers receiving 598 citations

Peers

Countries citing papers authored by Tony Marchand

Since Specialization

Citations

This map shows the geographic impact of Tony Marchand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tony Marchand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tony Marchand more than expected).

Fields of papers citing papers by Tony Marchand

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tony Marchand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tony Marchand. The network helps show where Tony Marchand may publish in the future.

Co-authorship network of co-authors of Tony Marchand

This figure shows the co-authorship network connecting the top 25 collaborators of Tony Marchand. A scholar is included among the top collaborators of Tony Marchand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tony Marchand. Tony Marchand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Haematopoietic stem cell number is not solely defined by niche availability 2025 ·Nature ·Shoichiro Takeishi, Tony Marchand, Wade Koba, Daniel K. Borger, (unknown), Chandan Guha, Aviv Bergman, Paul S. Frenette, Kira Gritsman, Ulrich Steidl	0
2	Diagnostic criteria for NK cell large granular lymphocyte leukemia: validation through a multicentric international study 2025 ·Blood Advances ·Cédric Pastoret, Jun Yang, David J. Feith, Mikaël Roussel, Aline Moignet, (unknown), Michael D. Solga, Tony Marchand, Gepke Visser, Vanessa Rebecca Gasparini, Antonella Teramo, Renato Zambello, Thomas P. Loughran, T. Lamy	0
3	Drug–drug interaction between letermovir and ciclosporin in allogeneic haematopoietic cell transplantation recipients 2025 ·Journal of Antimicrobial Chemotherapy ·(unknown), (unknown), Tony Marchand, Pascal Le Corre	0
4	Cefepime Concentration-Toxicity Relationship in Hematological Patients Treated With Continuous Infusion: A Prospective Study 2025 ·Clinical Infectious Diseases ·(unknown), (unknown), (unknown), Jeff Morçet, Tony Marchand, Roch Houot, Élisabeth Polard, Marie‐Clémence Verdier, F. Lemaı̂tre	1
5	A modern view of LGL leukemia 2024 ·Blood ·Tony Marchand, (unknown), Thomas P. Loughran	5
6	Efficacy of ruxolitinib in the treatment of relapsed/refractory large granular lymphocytic leukaemia 2024 ·British Journal of Haematology ·Tony Marchand, Cédric Pastoret, Gandhi Damaj, (unknown), Charles Herbaux, Aline Moignet, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Aspasia Stamatoullas, Christer Nilsson, (unknown), (unknown), Thierry Lamy	6
7	High CD44 expression and enhanced E-selectin binding identified as biomarkers of chemoresistant leukemic cells in human T-ALL 2024 ·Leukemia ·Julien Calvo, Irina Naguibneva, (unknown), (unknown), Benjamin Uzan, (unknown), (unknown), (unknown), Christophe Antoniewski, Hélène Lapillonne, Arnaud Petit, Paola Ballerini, Stéphane J.C. Mancini, Tony Marchand, Jean‐François Peyron, Françoise Pflumio	2
8	Tailored Digital PCR Follow-Up of Rare Fusion Transcripts after Initial Detection through RNA Sequencing in Hematological Malignancies 2024 ·Journal of Molecular Diagnostics ·Marie‐Laure Boulland, (unknown), (unknown), (unknown), (unknown), Damien Luque Paz, (unknown), (unknown), Sébastien Lachot, Audrey Basinko, (unknown), Sylvain Carras, (unknown), Tony Marchand, Marie de Tayrac, Thierry Fest, Roch Houot, Cédric Pastoret	1
9	Comparison of scoring systems evaluating suitability for intensive chemotherapy in adults with acute myeloid leukemia—a Grand Ouest Against Leukemia (GOAL) study 2022 ·Leukemia ·(unknown), Jérémie Riou, Pierre Péterlin, Tony Marchand, (unknown), Alban Villate, Jean-Baptiste Méar, (unknown), Gaëlle Guillerm, Emmanuel Gyan, Aline Schmidt, Roland B. Walter, Mathilde Hunault, Corentin Orvain	4
10	Toward a Better Classification System for NK-LGL Disorders 2022 ·Frontiers in Oncology ·(unknown), Cédric Pastoret, Aline Moignet, Thierry Lamy, Tony Marchand	6
11	Extracellular vesicles shed by follicular lymphoma B cells promote polarization of the bone marrow stromal cell niche 2021 ·Blood ·Erwan Dumontet, Céline Pangault, David Roulois, (unknown), Simon Léonard, Tony Marchand, Maëlle Latour, Patricia Legoix, Damarys Loew, Florent Dingli, Joëlle Dulong, Erwan Flécher, Cédric Coulouarn, Guillaume Cartron, Thierry Fest, Karin Tarte	17
12	Leukemic Stem Cells: From Leukemic Niche Biology to Treatment Opportunities 2021 ·Frontiers in Immunology ·Tony Marchand, Sandra Pinho	45
13	Arsenic trioxide is required in the treatment of newly diagnosed acute promyelocytic leukemia. Analysis of a randomized trial (APL 2006) by the French Belgian Swiss APL group 2018 ·Haematologica ·Lionel Adès, Xavier Thomas, (unknown), Emmanuel Raffoux, Olivier Spertini, Norbert Vey, Tony Marchand, Christian Récher, Arnaud Pigneux, Stéphane Girault, Éric Deconinck, Claude Gardin, Olivier Tournilhac, (unknown), Patrice Chevallier, Stéphane de Botton, Julie Lejeune, Hervé Dombret, Sylvie Chevret, Pierre Fenaux	21
14	Lineage-Biased Hematopoietic Stem Cells Are Regulated by Distinct Niches 2018 ·Developmental Cell ·Sandra Pinho, Tony Marchand, (unknown), Qiaozhi Wei, Claus Nerlov, Paul S. Frenette	153
15	IL-4/CXCL12 loop is a key regulator of lymphoid stroma function in follicular lymphoma 2017 ·Blood ·S. Pandey, Frédéric Mourcin, Tony Marchand, Saba Nayar, (unknown), Céline Pangault, Céline Monvoisin, Patricia Amé-Thomas, Fabien Guilloton, Joëlle Dulong, Mark Coles, Thierry Fest, Anja Mottok, Francesca Barone, Karin Tarte	67
16	Prise en charge nutritionnelle des patients hospitalisés pour allogreffe de CSH : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC) 2016 ·Bulletin du Cancer ·Jacques‐Olivier Bay, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Tony Marchand, (unknown), Sophie Servais, Ibrahim Yakoub‐Agha, D. Séguy	8
17	An early thymic precursor phenotype predicts outcome exclusively in HOXA-overexpressing adult T-cell acute lymphoblastic leukemia: a Group for Research in Adult Acute Lymphoblastic Leukemia study 2016 ·Haematologica ·Jonathan Bond, Tony Marchand, Aurore Touzart, Agata Cieślak, (unknown), Laurent Sutton, I Radford-Weiss, Ludovic Lhermitte, Salvatore Spicuglia, Hervé Dombret, Elizabeth Macintyre, Norbert Ifrah, J. F. Hamel, (unknown)	43
18	DC-SIGN–expressing macrophages trigger activation of mannosylated IgM B-cell receptor in follicular lymphoma 2015 ·Blood ·Rada Amin, Frédéric Mourcin, Fabrice Uhel, Céline Pangault, Philippe Ruminy, Loı̈c Dupré, (unknown), Tony Marchand, Thierry Fest, Thierry Lamy, Karin Tarte	92
19	Impact of Thymoglobulin by Stem Cell Source (Peripheral Blood Stem Cell or Bone Marrow) After Myeloablative Stem Cell Transplantation From HLA 10/10-Matched Unrelated Donors 2015 ·Transplantation ·(unknown), Aurélie Cabrespine, Gèrard Socié, Nöel Milpied, Ibrahim Yakoub‐Agha, Stephanie Nguyen, Mauricette Michallet, (unknown), Natacha Maillard, Mohamad Mohty, Felipe Suárez, Anne Huynh, Tony Marchand, (unknown), (unknown), Sébastien Maury, Patrice Chevallier, Oumédaly Reman, Régis Peffault de Latour, Jacques Olivier Bay	11
20	Cutaneous macroglobulinosis treated with bortezomib and rituximab 2011 ·European Journal Of Haematology ·Tony Marchand, Patrick Tas, Roch Houot, Charles Dauriac, Thierry Lamy, Xavier Cahu	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact